⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026

NSE

Godavari Biorefineries LimitedGODAVARIB

Godavari Biorefineries Limited is a leading manufacturer of chemicals, pharmaceuticals, and food products in India. The company operates primarily through its manufacturing and trading businesses.

Key productsPharmaceuticals, Food Products, Chemicals
GeographyIndia
CompetitorsGrasim Industries, Reliance Industries, Hindustan National Glass, IOL Chemicals & Pharmaceuticals

AI-generated overview — verify before relying on it.

Net institutional flow

27.1 Cr

Institutional buyers

0 in / 3 out

High-impact filings

0 · tilt Neutral

Next corporate action

Competitive landscape — the read

vs most-traded names · ALL
Institutional money is backing ATALREAL hardest (+7.2 Cr net). GODAVARIB ranks #4 of 7 on flow (net buying +0 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+7.2 Cr154
2MOBIKWIK+0.1 Cr83
3QUADFUTURE+0 Cr134
4GODAVARIBThis+0 Cr2
5MTNL+0 Cr2
6GATECH+0 Cr8
7IRMENERGY2.2 Cr328

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — GODAVARIB day by day

  1. 2026-06-16FilingGodavari Biorefineries Limited has informed the Exchange about Japanese Patent Office granted our patent, "5-HGeneral
  2. 2026-02-27BulkBUY · ₹8.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  3. 2026-02-27BulkSELL · ₹8.5 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  4. 2026-02-27NetDay net −₹0 Cr
  5. 2025-10-28BulkBUY · ₹7.1 CrCHAUBARA EATS PRIVATE LIMITED
  6. 2025-10-28BulkSELL · ₹7.1 CrCHAUBARA EATS PRIVATE LIMITED
  7. 2025-07-04BulkSELL · ₹8.2 Cr360 ONE EQUITY OPPORTUNITY FUND
  8. 2025-07-04BulkSELL · ₹6.6 CrTURNAROUND OPPORTUNITIES FUND
  9. 2025-07-04NetDay net −₹14.9 Cr
  10. 2024-10-30BulkSELL · ₹12.3 CrCAPRI GLOBAL CAPITAL LIMITED
  11. 2024-10-30BulkBUY · ₹16.8 CrMADHURI MADHUSUDAN KELA
  12. 2024-10-30BulkBUY · ₹10.1 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  13. 2024-10-30BulkSELL · ₹10.1 CrNK SECURITIES RESEARCH PRIVATE LIMITED
  14. 2024-10-30NetDay net +₹4.5 Cr

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

  • 2
    GeneralNeutral

    Japanese Patent Office granted our patent, "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER

    Source PDF →

Bulk & block deals

10 deals · 2024-10-30 → 2026-02-27

DateCounterpartyTypeSideValue
2026-02-27NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹8.5 Cr
2026-02-27NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELL₹8.5 Cr
2025-10-28CHAUBARA EATS PRIVATE LIMITEDHNI / otherBUY₹7.1 Cr
2025-10-28CHAUBARA EATS PRIVATE LIMITEDHNI / otherSELL₹7.1 Cr
2025-07-04360 ONE EQUITY OPPORTUNITY FUNDInstitutionSELL₹8.2 Cr
2025-07-04TURNAROUND OPPORTUNITIES FUNDInstitutionSELL₹6.6 Cr
2024-10-30CAPRI GLOBAL CAPITAL LIMITEDInstitutionSELL₹12.3 Cr
2024-10-30MADHURI MADHUSUDAN KELAHNI / otherBUY₹16.8 Cr
2024-10-30NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnBUY₹10.1 Cr
2024-10-30NK SECURITIES RESEARCH PRIVATE LIMITEDProp / churnSELL₹10.1 Cr

10 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on GODAVARIB

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.